Aspartic Protease Inhibitors: Effective Drugs against the Human Fungal Pathogen Candida albicans

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|13|1|155-162

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.13, Iss.1, 2013-01, pp. : 155-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis

By  

Current Medicinal Chemistry, Vol. 18, Iss. 16, 2011-06 ,pp. : 2401-2419

Bentham Science Publishers

Access to resources Recommend Favorite

Getting in Touch with Candida albicans: The Cell Wall of a Fungal Pathogen

By  

Current Drug Targets, Vol. 7, Iss. 4, 2006-04 ,pp. : 505-512

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of HDACs - Effective Drugs Against Cancer?

By  

Current Cancer Drug Targets, Vol. 10, Iss. 2, 2010-03 ,pp. : 210-228

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors

By  

Current Medicinal Chemistry, Vol. 14, Iss. 26, 2007-11 ,pp. : 2734-2748

Bentham Science Publishers

Access to resources Recommend Favorite

Caspofungin: effective against Candida infections

By  

Inpharma, Vol. 1, Iss. 1344, 2002-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite